Lixte Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.

About LIXT

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. 

CEO
Bastiaan van der Baan
CEOBastiaan van der Baan
Employees
4
Employees4
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
2005
Founded2005
Employees
4
Employees4

LIXT Key Statistics

Market cap
6.51M
Market cap6.51M
Price-Earnings ratio
-1.04
Price-Earnings ratio-1.04
Dividend yield
Dividend yield
Average volume
14.85K
Average volume14.85K
High today
$3.00
High today$3.00
Low today
$2.82
Low today$2.82
Open price
$3.00
Open price$3.00
Volume
10.20K
Volume10.20K
52 Week high
$9.50
52 Week high$9.50
52 Week low
$1.58
52 Week low$1.58
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.